[{"NetIncomeLoss_1_Q2_USD":-55147000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":null,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":22100000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":203000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":166144000.0,"AssetsCurrent_0_Q2_USD":329330000.0,"ContractWithCustomerLiability_0_Q2_USD":121600000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":null,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":10073277.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1993000.0,"CommonStockSharesIssued_0_Q2_shares":80005162.0,"Assets_0_Q2_USD":397113000.0,"ShareBasedCompensation_2_Q2_USD":17878000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":31617000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1557000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":13558443.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14075000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":25087000.0,"DepreciationAndAmortization_2_Q2_USD":3130000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":47818000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":642000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":178000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_2_Q2_USD":-411000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q2_USD":-207000.0,"CommonStockValue_0_Q2_USD":8000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":6836000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":173000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-107729000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-55354000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":9148000.0,"OtherAssetsNoncurrent_0_Q2_USD":5993000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":125713000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":41839000.0,"Liabilities_0_Q2_USD":212598000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-314000.0,"MarketableSecuritiesCurrent_0_Q2_USD":193857000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":10678000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":6568000.0,"OperatingIncomeLoss_2_Q2_USD":-107960000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":5081000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-207000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":9078000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-97236000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":261000000.0,"LiabilitiesCurrent_0_Q2_USD":74393000.0,"AccountsPayableCurrent_0_Q2_USD":11942000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":127185000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":9760000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":5867000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":3376000.0,"AdditionalPaidInCapital_0_Q2_USD":701670000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":969000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":348000.0,"ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_1_Q2_USD":700000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":28701000.0,"NetIncomeLoss_2_Q2_USD":-107318000.0,"RestrictedCashNoncurrent_0_Q2_USD":1472000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":93551000.0,"CommonStockSharesOutstanding_0_Q2_shares":80005162.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-517366000.0,"OperatingIncomeLoss_1_Q2_USD":-55325000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":25417000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":397113000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":17878000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":9078000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":71800000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":7760000.0,"OperatingExpenses_2_Q2_USD":118638000.0,"OperatingExpenses_1_Q2_USD":61893000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.35,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.69,"ProfitLoss_2_Q2_USD":-107318000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":158000.0,"StockholdersEquity_0_Q2_USD":184515000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":96208000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1775000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1152000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":75744000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-10678000.0,"Ticker":"ALEC","CIK":"1653087","name":"ALECTOR, INC.","OfficialName":"Alector Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"931151435.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]